Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

In vitro Mutagenesis

In vitro Mutagenesis

In-vitro Mutagenesis

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Carcinogenicity of butyl benzyl phthalate, dibutyl phthalate, and diisononyl phthalate.

The Lancet. Oncology·2026

Same author

Progress in identifying the preventable causes of human cancer: the experience of the IARC Monographs program.

Journal of the National Cancer Institute. Monographs·2026

Same author

Carcinogenicity of tris(chloropropyl) phosphate, butyraldehyde, and cumyl hydroperoxide.

The Lancet. Oncology·2026

Same author

Quantitative evaluation of genotoxicity data for risk assessment and regulatory decision-making: Time for a paradigm shift.

Environment international·2026

Same author

Carcinogenicity of atrazine, alachlor, and vinclozolin.

The Lancet. Oncology·2025

Same author

An evaluation of the utility of blood concentration of somatic mutagens to inform germ cell mutagenic hazard.

Regulatory toxicology and pharmacology : RTP·2025

Search research articles

Related Experiment Video

Updated: Mar 16, 2026

The Lambda Select cII Mutation Detection System

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

In vitro genotoxicity testing-Can the performance be enhanced?

Raffaella Corvi¹, Federica Madia¹

¹European Commission, Joint Research Centre (JRC), Directorate Health, Consumers and Reference Materials, Chemicals Safety and Alternative Methods Unit, EURL ECVAM, Via E. Fermi 2749, I-21027, Ispra, Varese, Italy.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association

|August 25, 2016

Summary

This summary is machine-generated.

Genotoxicity testing is crucial for substance safety assessment. Current in vitro methods are improving but cannot yet fully replace animal testing, necessitating ongoing research and tool development.

Keywords:

Alternative methods Genotoxicity In vitro mammalian cell test Safety assessment

More Related Videos

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Related Experiment Videos

Last Updated: Mar 16, 2026

The Lambda Select cII Mutation Detection System

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Area of Science:

Toxicology
In vitro testing
Regulatory science

Background:

Genotoxicity assessment is vital for chemical safety evaluations.
Existing in vitro genotoxicity tests are insufficient to replace animal studies.
Advancements in genotoxicity testing are needed to improve substance safety assessments.

Purpose of the Study:

To outline recent advancements in genotoxicity testing.
To highlight the development of novel in vitro assays.
To discuss strategies for optimizing in vitro test accuracy.

Main Methods:

Review of current in vitro genotoxicity testing strategies.
Exploration of new assay development and validation.
Analysis of supporting tools like databases and reference lists.

Main Results:

Improvement of existing genotoxicity assays.
Development of novel in vitro testing methods.
Creation of databases and reference chemical lists to aid research.

Conclusions:

Ongoing efforts are enhancing genotoxicity testing paradigms.
Optimizing in vitro accuracy is key to reducing animal testing.
Further development of tools and methods is essential for comprehensive safety assessment.